Home

Slika Kantina Prašina prognostic marker Povlačenje tanjur Odseci

PLOS ONE: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast  Cancer and Nodal Metastasis Involvement
PLOS ONE: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement

Current and future biomarkers for risk-stratification and treatment  personalisation in multiple myeloma - Molecular Omics (RSC Publishing)
Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma - Molecular Omics (RSC Publishing)

Almost all articles on cancer prognostic markers report statistically  significant results - European Journal of Cancer
Almost all articles on cancer prognostic markers report statistically significant results - European Journal of Cancer

Prognostic and predictive factors for lung cancer | European Respiratory  Society
Prognostic and predictive factors for lung cancer | European Respiratory Society

Candidate prognostic markers in breast cancer: focus on extracellular | BCTT
Candidate prognostic markers in breast cancer: focus on extracellular | BCTT

Prognostic Biomarkers | OncologyPRO
Prognostic Biomarkers | OncologyPRO

Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative  systematic review - European Journal of Obstetrics and Gynecology and  Reproductive Biology
Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review - European Journal of Obstetrics and Gynecology and Reproductive Biology

Correlation of investigated prognostic markers and clinical outcomes of...  | Download Table
Correlation of investigated prognostic markers and clinical outcomes of... | Download Table

PLOS ONE: Pyruvate kinase M2 is a poor prognostic marker of and a  therapeutic target in ovarian cancer
PLOS ONE: Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19  patients - Clinical Nutrition ESPEN
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN

Red cell distribution width as a prognostic marker in patients with  community-acquired pneumonia - The American Journal of Emergency Medicine
Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia - The American Journal of Emergency Medicine

bcl-2 expression in head and neck cancer: an enigmatic prognostic marker -  International Journal of Radiation Oncology, Biology, Physics
bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics

Asparaginase-like protein 1 is an independent prognostic marker in primary  endometrial cancer, and is frequently lost in metastatic lesions -  Gynecologic Oncology
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions - Gynecologic Oncology

CEA - Prognostic Marker for Breast Cancer: GOHEL, Dr HARDIK R:  9781794454927: Amazon.com: Books
CEA - Prognostic Marker for Breast Cancer: GOHEL, Dr HARDIK R: 9781794454927: Amazon.com: Books

Thyroid hormones ratio is a major prognostic marker in advanced metastatic  colorectal cancer: Results from the phase III randomised CORRECT trial -  European Journal of Cancer
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer

Prognostic markers
Prognostic markers

COVID-19 related neuroimaging findings: A signal of thromboembolic  complications and a strong prognostic marker of poor patient outcome -  Journal of the Neurological Sciences
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences

Prognostic markers in cancer: the evolution of evidence from single studies  to meta-analysis, and beyond | British Journal of Cancer
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer

Prognostic and predictive markers in pancreatic adenocarcinoma - Digestive  and Liver Disease
Prognostic and predictive markers in pancreatic adenocarcinoma - Digestive and Liver Disease

SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC  CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology
SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and  therapeutic target in osteosarcoma - EBioMedicine
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma - EBioMedicine

Differential analysis revealing APOC1 to be a diagnostic and prognostic  marker for liver metastases of colorectal cancer
Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer

K17, a prognostic marker in cervical cancer independent of tumor stage....  | Download Scientific Diagram
K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram

The Prognostic Marker Detected in Serum for CCA | Download Scientific  Diagram
The Prognostic Marker Detected in Serum for CCA | Download Scientific Diagram

Cell free nucleic acids as diagnostic and prognostic marker in leukemia |  Semantic Scholar
Cell free nucleic acids as diagnostic and prognostic marker in leukemia | Semantic Scholar

A. VeriStrat as a prognostic marker among patients who had active... |  Download Scientific Diagram
A. VeriStrat as a prognostic marker among patients who had active... | Download Scientific Diagram

Epithelial-to-mesenchymal transition is a prognostic marker for patient  outcome in advanced stage HNSCC patients treated with chemoradiotherapy -  Radiotherapy and Oncology
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy - Radiotherapy and Oncology